Skip to main content
SpringerLink
Log in

Abiraterone/enzalutamide

Lung injury (first report with enzalutamide), heart failure and left ventricular systolic dysfunction: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Tsugu T, et al. Cancer therapeutics-related cardiac dysfunction in a patient treated with abiraterone for castration-resistant prostate cancer. Journal of Medical Ultrasonics 46: 239-243, No. 2, Apr 2019. Available from: URL: http://doi.org/10.1007/s10396-018-0897-7 - Japan

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abiraterone/enzalutamide. Reactions Weekly 1750, 14 (2019). https://doi.org/10.1007/s40278-019-60878-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-60878-6

Search

Navigation